Georgia Cannabis Software

How Georgia Regulates Cannabis Licenses

Georgia operates one of the most narrowly defined cannabis programs in the United States. Unlike the majority of states that have legalized medical marijuana in the traditional sense allowing patients to purchase and consume cannabis flower, edibles, or inhaled products Georgia is specifically a low-THC oil registry state. Recreational cannabis is not legal in Georgia, and the state does not permit the possession, sale, or use of cannabis flower or plant material in any form. What Georgia does authorize, under a carefully structured licensing framework, is the cultivation, production, and dispensing of low-THC oil products by a small number of licensed operators.

The governing body for cannabis licensing in Georgia is the Georgia Access to Medical Cannabis Commission (GMCC), established under the Georgia's Hope Act (HB 324), signed into law by Governor Brian Kemp on April 17, 2019. The GMCC oversees the licensing of producers and dispensaries, while the Georgia Department of Public Health (DPH) manages the patient-facing side of the program specifically the Low THC Oil Registry, which qualified patients must be enrolled in to legally possess low-THC oil. The Georgia Department of Agriculture (GDA) handles a separate track for industrial hemp licensing, which operates entirely outside of the GMCC's authority.

Sales from licensed Georgia cannabis dispensaries began in 2023, and as of early 2026, the state's Low THC Oil Registry has grown to more than 33,700 patients, approximately 2,300 caregivers, and over 700 certifying physicians. Georgia's 2026 legislative session has seen active debate around potential program expansion including Senate Bill 220, which passed the Senate in March 2025 and carries over into 2026 but as of the current session, the core licensing structure and THC limits described here remain the operative law. Operators and applicants should monitor GMCC announcements closely for any changes that may take effect during or after the 2026 session.

What Qualifies as Low-THC Oil in Georgia

Before covering license types, operators entering the Georgia market need to understand the foundational product definition that governs the entire program. Under Georgia law, low-THC oil is defined as an oil that contains no more than 5% tetrahydrocannabinol (THC) by weight and an amount of cannabidiol (CBD) that is equal to or greater than the amount of THC. This dual requirement a 5% THC ceiling and a mandatory CBD-to-THC ratio is not found in most other state programs and is a critical compliance detail for producers. A product that meets the THC threshold but falls short on CBD content is not legally compliant in Georgia.

Registered patients may legally possess up to 20 fluid ounces of low-THC oil at any time, provided they hold an active Low THC Oil Registry Card issued by the Georgia Department of Public Health and that the oil is stored in a pharmaceutical container labeled by the manufacturer indicating the THC percentage. Products approved for sale include oils, tinctures, transdermal patches, lotions, and capsules. Edible products, vaporization, and raw flower remain explicitly prohibited under current Georgia law a restriction that has been a focal point of ongoing legislative debate.

Class 1 Production License

The Class 1 Production License is Georgia's large-scale cannabis cultivation and manufacturing license. It authorizes the licensee to cultivate cannabis with a canopy of up to 100,000 square feet and to manufacture low-THC oil from that cultivation. Georgia maintains a strict cap on the total number of Class 1 licenses only two Class 1 licenses are authorized under state law, making this one of the most tightly restricted production licenses in the country. Both Class 1 licenses have been awarded, meaning this license type is not currently open for new applicants unless a license becomes available through revocation or legislative change.

The fee structure for a Class 1 Production License is among the highest of any state cannabis license in the Southeast. The application fee is $25,000, the initial license fee is $200,000, and the annual renewal fee is $100,000. A change fee of $1,000 applies for any name, ownership, or agent modifications. All application fees are nonrefundable and nontransferable. Payments for production license application fees must be made by certified funds either a cashier's check or money order made payable to the Georgia Access to Medical Cannabis Commission. No cash or personal checks are accepted.

A key compliance consideration for Class 1 licensees is that while Georgia law does not explicitly prohibit an entity from applying for both Class 1 and Class 2 production licenses, restrictions on ownership interests apply if both are awarded. Operators with dual-license ambitions need to structure their ownership arrangements carefully before submitting applications to avoid triggering these restrictions after the fact.

Class 2 Production License

The Class 2 Production License is designed for smaller-scale cannabis cultivation and manufacturing operations. It authorizes a cultivation canopy of up to 40,000 square feet and similarly allows for the manufacturing of low-THC oil. Georgia law authorizes four Class 2 licenses in total. The Georgia Access to Medical Cannabis Commission issued all four Class 2 licenses to cultivators in November 2023, meaning this license type is also fully awarded under the current statutory cap.

The Class 2 Production License application fee is $5,000, the initial license fee is $100,000, and the annual renewal fee is $50,000. The $1,000 change fee for name, ownership, or agent modifications also applies. As with Class 1, all fees are nonrefundable and nontransferable, and payments for application fees must be submitted by certified funds. Financial requirements previously established during the original licensing rounds included proof of at least $1.25 million in available cash reserves and a $625,000 cash bond payable to the state figures that reflect the significant capitalization requirements Georgia placed on production operators from the outset.

Dispensing License

The Dispensing License authorizes a licensed entity to sell low-THC oil products directly to registered patients and their caregivers. Only dispensaries licensed by the Georgia Access to Medical Cannabis Commission or the Georgia Board of Pharmacy may sell low-THC oil in Georgia. As of late 2025, Georgia has approximately 17 to 19 licensed dispensaries operating statewide, in addition to over 56 independent pharmacies that have been authorized by the Georgia Board of Pharmacy to carry low-THC products. Georgia made history as the first state in the country to permit the sale of cannabis products through independent drug stores, allowing patients in areas without a nearby dispensary to access low-THC oil closer to home.

The fee structure for the Dispensing License is tiered based on the county in which the dispensary will operate, with four county tiers reflecting differences in population and market demand. The application fee is $5,000 across all tiers. Initial license fees range from $15,000 for Tier 1 counties to $30,000 for Tier 4 counties. Annual renewal fees range from $25,000 for Tier 1 counties to $40,000 for Tier 4 counties. A $1,000 change fee applies for any dispensing license modifications involving name, ownership, or agent. Unlike production license fees, dispensing license fees may be paid by business check in addition to certified funds.

One compliance gotcha specific to the Dispensing License: patients must present their active Low THC Oil Registry Card at the point of sale. Dispensaries are responsible for verifying registry card status at the time of purchase, and selling to a patient whose card has expired or been revoked creates direct compliance exposure for the license holder. The GMCC has authority to investigate complaints and pursue disciplinary action against licensed dispensaries, including license suspension or revocation for violations.

Independent Laboratory Registration

Georgia requires that all low-THC oil products be tested by an independent laboratory registered with the GMCC before they can be sold to patients. The Independent Laboratory Registration is not a production or retail license it is a registration specifically for third-party testing facilities that analyze cannabis products for THC content, CBD content, contaminants, and overall safety before products reach dispensary shelves.

The initial registration fee for an independent laboratory is $10,000. Renewal fees escalate on a tiered schedule: $1,500 for the first annual renewal, $2,500 for the second, $5,000 for the third, and $10,000 for the fourth and all subsequent annual renewals. A $1,000 change fee applies for modifications to the laboratory's name, location, or agent. This escalating renewal structure is unusual compared to most state cannabis testing frameworks and means that a laboratory's annual compliance cost rises significantly in its first four years of operation before stabilizing.

Hemp Licensing in Georgia

Industrial hemp licensing in Georgia operates on an entirely separate track from the GMCC's medical cannabis program. The Georgia Department of Agriculture regulates licensing for industrial hemp in Georgia. Hemp producers and processors in Georgia apply through the GDA under the Georgia Hemp Farming Act, which permits the cultivation and sale of hemp and hemp-derived products containing no more than 0.3% THC. The two primary license types under the GDA's hemp program are the Grower's License, for entities cultivating hemp, and the Processor's License, for entities processing raw hemp into finished products. Hemp licensees are subject to annual renewal, mandatory THC testing, and regular GDA inspections and non-compliance can result in license revocation or financial penalties.

It is important to understand that hemp licensing and GMCC medical cannabis licensing are legally and operationally distinct in Georgia. A hemp processor license does not authorize the production of low-THC oil for the medical cannabis program, and a GMCC production license does not authorize activities under the hemp program. Operators interested in both markets must obtain the appropriate license from each respective agency.

Seed-to-Sale Tracking in Georgia

Georgia does not have a government-mandated contract with a third-party seed-to-sale tracking provider. Unlike most cannabis states that require all licensees to report activity into a state-contracted system such as Metrc or BioTrack, Georgia requires licensed producers, manufacturers, and dispensaries to self-report seed-to-sale activities without a designated state platform. The GMCC has established rules governing seed-to-sale tracking requirements under Chapter 351-5 of the Georgia Administrative Code, which covers tracking system operations, approved tracking system requirements, and plant and product tag standards. Licensed operators must be able to demonstrate full traceability of cannabis products from cultivation through point of sale and are required to submit a seed-to-sale tracking plan as part of both the production license and dispensing license applications. Non-compliance with tracking requirements can result in fines, license suspension, or revocation.

The absence of a state-contracted system means Georgia operators carry more internal responsibility for building and maintaining their own tracking infrastructure than operators in Metrc or BioTrack states. Any tracking system used must meet the GMCC's approved requirements and must be capable of generating the documentation regulators require during inspections. This is a meaningful operational distinction that operators new to Georgia particularly those coming from heavily standardized Metrc states should plan for carefully before launch.

Compliance Considerations for Georgia Cannabis Operators

With only six production licensees total two Class 1 and four Class 2 and a hard statutory cap on license numbers, the operator landscape in Georgia is extremely concentrated. Every licensee is operating under significant public scrutiny and regulatory oversight, which makes day-to-day compliance management more consequential than in open-market states with hundreds of licensees.

Several compliance details are worth internalizing before operations begin. First, the dual-requirement product definition THC at or below 5% by weight, CBD at or above THC content must be verified at the batch level through an GMCC-registered independent laboratory before any product can be sold. Second, the possession limit for patients is fixed at 20 fluid ounces of low-THC oil, and dispensaries are responsible for ensuring sales do not exceed this threshold to any individual patient. Third, all products must be sold in pharmaceutical containers labeled with the THC percentage by the manufacturer products not meeting this labeling standard cannot be legally dispensed regardless of their chemical composition.

Finally, operators should closely monitor the Georgia General Assembly's 2026 session, which runs through April 2, 2026. Senate Bill 220 which passed the Senate in a 39-17 vote in March 2025 and carries over into 2026 proposes significant changes to the program, including shifting from a 5% THC percentage cap to a 12,000 milligram THC limit and potentially allowing vaporization. If SB 220 or similar legislation passes and is signed into law, it would represent the most substantial change to Georgia's medical cannabis framework since the Hope Act and would have direct implications for production, labeling, and dispensing operations statewide.